Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neuroscience ; 158(3): 983-94, 2009 Feb 06.
Artigo em Inglês | MEDLINE | ID: mdl-18621108

RESUMO

Regulation of the extracellular matrix by proteases and protease inhibitors is a fundamental biological process for normal growth, development and repair in the CNS. Matrix metalloproteinases (MMPs) and the tissue inhibitors of metalloproteinases (TIMPs) are the major extracellular-degrading enzymes. Two other enzyme families, a disintegrin and metalloproteinase (ADAM), and the serine proteases, plasminogen/plasminogen activator (P/PA) system, are also involved in extracellular matrix degradation. Normally, the highly integrated action of these enzyme families remodels all of the components of the matrix and performs essential functions at the cell surface involved in signaling, cell survival, and cell death. During the inflammatory response induced in infection, autoimmune reactions and hypoxia/ischemia, abnormal expression and activation of these proteases lead to breakdown of the extracellular matrix, resulting in the opening of the blood-brain barrier (BBB), preventing normal cell signaling, and eventually leading to cell death. There are several key MMPs and ADAMs that have been implicated in neuroinflammation: gelatinases A and B (MMP-2 and -9), stromelysin-1 (MMP-3), membrane-type MMP (MT1-MMP or MMP-14), and tumor necrosis factor-alpha converting enzyme (TACE). In addition, TIMP-3, which is bound to the cell surface, promotes cell death and impedes angiogenesis. Inhibitors of metalloproteinases are available, but balancing the beneficial and detrimental effects of these agents remains a challenge.


Assuntos
Barreira Hematoencefálica/enzimologia , Isquemia Encefálica/enzimologia , Encefalite/enzimologia , Matriz Extracelular/enzimologia , Metaloproteinases da Matriz/metabolismo , Inibidores Teciduais de Metaloproteinases/metabolismo , Animais , Autoimunidade/imunologia , Barreira Hematoencefálica/imunologia , Barreira Hematoencefálica/fisiopatologia , Edema Encefálico/enzimologia , Edema Encefálico/imunologia , Edema Encefálico/fisiopatologia , Isquemia Encefálica/imunologia , Isquemia Encefálica/fisiopatologia , Morte Celular/imunologia , Encefalite/imunologia , Encefalite/fisiopatologia , Humanos , Metaloproteinases da Matriz/imunologia , Degeneração Neural/enzimologia , Degeneração Neural/imunologia , Degeneração Neural/fisiopatologia , Inibidores Teciduais de Metaloproteinases/imunologia
2.
Methods Find Exp Clin Pharmacol ; 28(6): 369-72, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16894406

RESUMO

Coffee, one of the most excessively used beverages worldwide, commences the risk of gastroesophageal reflux (GER), which may lead to gastric ulcers and increase the risk of gastric cancer. Many attempts have been made by the coffee industry to diminish the irritating effect on mucosa by means of altering the extraction methods concerning gerbic acids and the roasting processes. This paper describes the effect of differently produced coffees involving two brands of Darboven and two brands of other coffee roasters. The aim of this study was to prove the results of gastric potential measurements we found in literature by using human AGS gastric epithelial cells (human adenocarcinoma). All four coffee extracts tested differentially affected the membrane resting potential of AGS cells. Coffees no. 1 and no. 2 depolarized the cells, presumably by increasing the cation entry into the cytosol. In marked contrast, coffee no. 4 hyperpolarizes the cells, possibly by H(+) extrusion and/or Cl(-) influx, suggesting that this coffee might increase acidity in the stomach, which might negatively affect the stomach, especially in people with gastroesophageal reflux symptoms. Overall, our data suggest that different roasting methods of coffees affect the membrane potentials of AGS stomach cells, resulting in increased influx of H+ possibly resulting in decreased stomach acidity and thus reducing GER. These results are in good accordance with clinical pharmacological results from potential difference measurements in healthy volunteers we found in the literature.


Assuntos
Café , Estômago/citologia , Adenocarcinoma/patologia , Cátions/análise , Linhagem Celular Tumoral , Membrana Celular/efeitos dos fármacos , Café/química , Ácido Gástrico/metabolismo , Determinação da Acidez Gástrica , Humanos , Potenciais da Membrana/efeitos dos fármacos , Técnicas de Patch-Clamp , Extratos Vegetais/farmacologia , Estômago/efeitos dos fármacos , Neoplasias Gástricas/patologia
3.
Scand J Rheumatol Suppl ; 119: 9-11, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15515405

RESUMO

There is evidence from both human and animal research that 5-hydroxytryptamine3 (5-HT3) receptor antagonists, particularly tropisetron, exert analgesic and antiinflammatory effects. However, the underlying mechanisms of these effects including the expression of 5-HT3 receptors in cells of the immune system have not yet been investigated in detail. Therefore, we investigated the expression of the 5-HT3A receptor in primary human monocytes, chondrocytes, T-cells, dendritic cells, and synovial tissue. We found that 5-HT3A receptors are expressed in monocytes, chondrocytes, T-cells, and synovial tissue but not in dendritic cells. Our data show that 5-HT3A receptors are widely expressed in cells of the immune system and that they might play an important role in inflammatory events and in the observed antiphlogistic effects of 5-HT3 receptor antagonists.


Assuntos
Receptores 5-HT3 de Serotonina/biossíntese , Células Dendríticas/imunologia , Humanos , Sistema Imunitário/citologia , Sistema Imunitário/fisiologia , Monócitos/imunologia , Linfócitos T/imunologia
4.
Scand J Rheumatol Suppl ; 119: 28-32, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15515409

RESUMO

There is evidence from both human and animal research that 5-hydroxytryptamine (5-HT)3 receptor antagonists, particularly tropisetron, exert analgesic and antiinflammatory effects. However, the underlying mechanisms of these effects have not yet been investigated in detail. Therefore, the antiinflammatory effects of tropisetron and ondansetron were investigated in human monocytes. In human monocytes, both lipopolysaccharide (LPS)-stimulated tumour necrosis factor (TNF)-alpha and interleukin (IL)-1beta secretion were dose-dependently inhibited by tropisetron starting at a concentration of 5 microg/mL and reaching maximal levels at 25 microg/mL (IC50: 32 microg/mL and 12 microg/mL, respectively). LPS-induced IL-6 and PGE2 release was only slightly inhibited at high doses, whereas LPS-induced release of IL-8 and matrix metalloprotease (MMP)-9 was not affected. In conclusion, our data show that the binding of tropisetron to 5-HT3 receptors results in antiinflammatory effects through inhibition of TNF-alpha/IL-1beta, which might explain the antiphlogistic effects of 5-HT3 antagonists.


Assuntos
Indóis/uso terapêutico , Inflamação/tratamento farmacológico , Monócitos/efeitos dos fármacos , Monócitos/imunologia , Antagonistas do Receptor 5-HT3 de Serotonina , Antagonistas da Serotonina/uso terapêutico , Células Cultivadas , Humanos , Lipopolissacarídeos/farmacologia , Tropizetrona
6.
Liver Int ; 24(1): 55-62, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15102001

RESUMO

BACKGROUND: Many studies indicate that oxygen free-radical formation after reoxygenation of liver may initiate the cascade of hepatocellular injury. It has been demonstrated that controlled ozone administration may promote an oxidative preconditioning or adaptation to oxidative stress, preventing the damage induced by reactive oxygen species and protecting against liver ischaemia-reperfusion (I/R) injury. AIMS: In the present study, the effects of ozone oxidative preconditioning (OzoneOP) on nitric oxide (NO) generation and the cellular redox balance have been studied. METHODS: Six groups of rats were classified as follows: (1). sham-operated; (2). sham-operated+l-NAME (N(omega)-nitro-l-arginine methyl ester); (3). I/R (ischaemia 90 min-reperfusion 90 min); (4). OzoneOP+I/R; (5). OzoneOP+l-NAME+I/R; and (6). l-NAME+I/R. The following parameters were measured: plasma transaminases (aspartate aminotransferase, alanine aminotransferase) as an index of hepatocellular injury; in homogenates of hepatic tissue: nitrate/nitrite as an index of NO production; superoxide dismutase (SOD), catalase (CAT) and glutathione levels as markers of endogenous antioxidant system; and finally malondialdehyde+4-hydroxyalkenals (MDA+4-HDA) and total hydroperoxides (TH) as indicators of oxidative stress. RESULTS: A correspondence between liver damage and the increase of NO, CAT, TH, glutathione and MDA+4-HDA concentrations were observed just as a decrease of SOD activity. OzoneOP prevented and attenuated hepatic damage in I/R and OzoneOP+l-NAME+I/R, respectively, in close relation with the above-mentioned parameters. CONCLUSIONS: These results show that OzoneOP protected against liver I/R injury through mechanisms that promote a regulation of endogenous NO concentrations and maintenance of cellular redox balance. Ozone treatment may have important clinical implications, particularly in view of the increasing hepatic transplantation programs.


Assuntos
Óxido Nítrico/biossíntese , Oxidantes Fotoquímicos/administração & dosagem , Ozônio/administração & dosagem , Traumatismo por Reperfusão/prevenção & controle , Adaptação Fisiológica/efeitos dos fármacos , Animais , Fígado/irrigação sanguínea , Fígado/efeitos dos fármacos , Masculino , Modelos Animais , Oxirredução/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Ratos , Ratos Wistar , Espécies Reativas de Oxigênio/metabolismo , Traumatismo por Reperfusão/metabolismo
7.
J Appl Toxicol ; 21(5): 403-7, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11746182

RESUMO

Some markers of oxidative injury were measured in different rat brain areas (hippocampus, cerebral cortex, striatum, hypothalamus, amygdala/piriform cortex and cerebellum) after the systemic administration of an excitotoxic dose of kainic acid (KA, 9 mg kg(-1) i.p.) at two different sampling times (24 and 48 h). Kainic acid was able to lower markedly (P < 0.05) the glutathione (GSH) levels in hippocampus, cerebellum and amygdala/piriform cortex (maximal reduction at 24 h). In a similar way, lipid peroxidation, as assessed by malonaldehyde and 4-hydroxyalkenal levels, significantly increased (P < 0.05) in hippocampus, cerebellum and amygdala/piriform cortex mainly at 24 h after KA. In addition, hippocampal superoxide dismutase (SOD) activity decreased significantly (P < 0.05) with respect to basal levels by 24 h after KA application. On the other hand, brain areas such as hypothalamus, striatum and cerebral cortex seem to be less susceptible to KA excitotoxicity. According to these findings, the pattern of oxidative injury induced by systemically administered KA seems to be highly region-specific. Further, our results have shown that a lower antioxidant status (GSH and SOD) seems not to play an important role in the selective vulnerability of certain brain regions because it correlates poorly with increases in markers of oxidative damage.


Assuntos
Encéfalo/efeitos dos fármacos , Antagonistas de Aminoácidos Excitatórios/toxicidade , Ácido Caínico/toxicidade , Estresse Oxidativo/efeitos dos fármacos , Animais , Comportamento Animal/efeitos dos fármacos , Encéfalo/metabolismo , Antagonistas de Aminoácidos Excitatórios/administração & dosagem , Glutationa/metabolismo , Injeções Intraperitoneais , Ácido Caínico/administração & dosagem , Peroxidação de Lipídeos , Masculino , Proteínas/metabolismo , Ratos , Ratos Sprague-Dawley , Superóxido Dismutase/metabolismo
8.
Pharmacol Res ; 44(5): 391-6, 2001 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11712870

RESUMO

Ozone has been used as a therapeutical agent and beneficial effects have been observed. However so far only a few biochemical and pharmacodynamic mechanisms have been elucidated. We demonstrate that controlled ozone administration may promote an oxidative preconditioning or adaptation to oxidative stress, preventing the damage induced by reactive oxygen species (ROS). Taking into account that diabetes is a disorder associated with oxidative stress, we postulate that ozone treatment in our experimental conditions might protect antioxidant systems and maintain, at a physiological level, other markers of endothelial cell damage associated with diabetic complications. Five groups of rats were classified as follows: (1) control group treated only with physiological saline solution; (2) positive control group using streptozotocin (STZ) as a diabetes inductor; (3) ozone group, receiving 10 treatments (1.1 mg kg(-1)), one per day after STZ-induced diabetes; (4) oxygen group (26 mg kg(-1)), one per day, as in group 3 but using oxygen only; (5) control ozone group, as group 3, but without STZ. The ozone treatment improved glycemic control and prevented oxidative stress, the increase of aldose reductase, fructolysine content and advanced oxidation protein products. Nitrite and nitrate levels were maintained without changes with regard to non-diabetic control. The results of this study show that repeated administration of ozone in non-toxic doses might play a role in the control of diabetes and its complications.


Assuntos
Diabetes Mellitus Experimental/metabolismo , Endotélio Vascular/metabolismo , Endotélio Vascular/patologia , Oxidantes Fotoquímicos/farmacologia , Estresse Oxidativo/efeitos dos fármacos , Ozônio/uso terapêutico , Animais , Biomarcadores/análise , Peso Corporal/efeitos dos fármacos , Diabetes Mellitus Experimental/sangue , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Experimental/fisiopatologia , Endotélio Vascular/efeitos dos fármacos , Glicosilação/efeitos dos fármacos , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Nitratos/metabolismo , Óxido Nítrico/biossíntese , Nitritos/metabolismo , Oxidantes Fotoquímicos/uso terapêutico , Oxirredução/efeitos dos fármacos , Ozônio/administração & dosagem , Proteínas/metabolismo , Ratos , Ratos Sprague-Dawley
9.
Neurosci Res ; 41(3): 233-41, 2001 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11672836

RESUMO

The time course of oxidative damage in different brain regions was investigated in the gerbil model of transient cerebral ischemia. Animals were subjected to both common carotid arteries occlusion for 5 min. After the end of ischemia and at different reperfusion times (2, 6, 12, 24, 48, 72, 96 h and 7 days), markers of lipid peroxidation, reduced and oxidized glutathione levels, glutathione peroxidase, glutathione reductase, manganese-dependent superoxide dismutase (MnSOD) and copper/zinc containing SOD (Cu/ZnSOD) activities were measured in hippocampus, cortex and striatum. Oxidative damage in hippocampus was maximal at late stages after ischemia (48-96 h) coincident with a significant impairment in glutathione homeostasis. MnSOD increased in hippocampus at 24, 48 and 72 h after ischemia, coincident with the marked reduction in the activity of glutathione-related enzymes. The late disturbance in oxidant-antioxidant balance corresponds with the time course of delayed neuronal loss in the hippocampal CA1 sector. Cerebral cortex showed early changes in oxidative damage with no significant impairment in antioxidant capacity. Striatal lipid peroxidation significantly increased as early as 2 h after ischemia and persisted until 48 h with respect to the sham-operated group. These results contribute significant information on the timing and factors that influence free radical formation following ischemic brain injury, an essential step in determining effective antioxidant intervention.


Assuntos
Encéfalo/metabolismo , Ataque Isquêmico Transitório/metabolismo , Estresse Oxidativo , Animais , Gerbillinae , Glutationa/metabolismo , Peróxidos Lipídicos/metabolismo , Masculino , Oxirredutases/metabolismo , Fatores de Tempo
10.
J Appl Toxicol ; 21(4): 297-301, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11481663

RESUMO

The rectal insufflation of a judicious dose of ozone, selected from that used in clinical practice, is able to promote oxidative preconditioning or oxidative stress tolerance preventing the hepatocellular damage mediated by free radicals. In order to evaluate the effects of ozone oxidative preconditioning on carbon tetrachloride-mediated hepatotoxicity, the following experimental protocol was designed: group 1 (negative control, sunflower oil i.p.); group 2 (CCl(4) in sunflower oil, 1 ml kg(-1) i.p.); group 3 (15 ozone-oxygen pretreatments at a dose of 1 mg kg(-1) via rectal insufflation + CCl(4) as in group 2); group 4 (ozone control group, 15 ozone-oxygen pretreatments + sunflower oil i.p.). Ozone pretreatment prevented glycogen depletion (as demonstrated by biochemical and histopathological findings) and avoided lactate overproduction associated with the hepatotoxic effects of CCl(4). The administration of CCl(4) increased lipid peroxidation (as measured by thiobarbituric acid-reactive substances) and uric acid levels and inhibited superoxide dismutase activity. All these deleterious effects induced by CCl(4) were prevented by ozone pretreatment. The administration of ozone without CCl(4) (ozone control group) did not produce any changes in the evaluated parameters. Our results showed that ozone treatment, in our experimental conditions, was able to prevent anaerobic glycolysis and oxidative stress induced by CCl(4).


Assuntos
Antioxidantes/farmacologia , Intoxicação por Tetracloreto de Carbono/prevenção & controle , Glicogênio/deficiência , Fígado/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Ozônio/farmacologia , Animais , Peso Corporal/efeitos dos fármacos , Intoxicação por Tetracloreto de Carbono/tratamento farmacológico , Catalase/análise , Feminino , Sequestradores de Radicais Livres/antagonistas & inibidores , Glicólise/efeitos dos fármacos , Injeções Intraperitoneais , Insuflação , Ácido Láctico/análise , Peroxidação de Lipídeos/efeitos dos fármacos , Fígado/metabolismo , Fígado/patologia , Tamanho do Órgão/efeitos dos fármacos , Ozônio/administração & dosagem , Proteínas/análise , Ratos , Ratos Sprague-Dawley , Superóxido Dismutase/análise , Substâncias Reativas com Ácido Tiobarbitúrico/análise , Ácido Úrico/análise
11.
Free Radic Res ; 35(5): 465-73, 2001 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11767405

RESUMO

The effect of oral administration of Mangifera indica L. extract (QF808) on ischemia-reperfusion-induced neuronal death in the gerbil hippocampal CA1 sector was examined. Oral administration of QF808 for 7 days dose-dependently protected against neuronal cell death following transient ischaemia and reperfusion as assessed by histopathology. In addition, locomotor activity assessment prior to ischaemia and 7 days after correlated well with the histological results. To evaluate redox alterations by reactive oxygen species, total sulfhydryl, non-protein sulfhydryl groups (NPSH), malondialdehyde + 4-hydroxyalkenals and total nitrogen oxide levels were assayed in hippocampus and cortex homogenates. QF808 treatment attenuated NPSH loss, nitrogen oxide levels and lipid peroxidation in the hippocampus. These results suggest that orally administered QF808 is absorbed across the blood-brain barrier and attenuates neuronal death of the hippocampal CA1 area after ischaemia-reperfusion. These protective effects are most likely due to the antioxidant activity of QF808.


Assuntos
Isquemia Encefálica/tratamento farmacológico , Encéfalo/efeitos dos fármacos , Magnoliopsida , Fitoterapia , Extratos Vegetais/farmacologia , Animais , Antioxidantes/farmacologia , Encéfalo/metabolismo , Encéfalo/patologia , Isquemia Encefálica/metabolismo , Isquemia Encefálica/patologia , Morte Celular/efeitos dos fármacos , Córtex Cerebral/efeitos dos fármacos , Córtex Cerebral/metabolismo , Córtex Cerebral/patologia , Gerbillinae , Masculino , Atividade Motora/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Neurônios/patologia , Células Piramidais/efeitos dos fármacos , Células Piramidais/metabolismo , Células Piramidais/patologia
12.
Eur J Pharmacol ; 390(3): 295-8, 2000 Mar 03.
Artigo em Inglês | MEDLINE | ID: mdl-10708736

RESUMO

Kainate induces a marked expression of cyclooxygenase-2 after its systemic administration. Because cyclooxygenase-2 activity is associated to the production of reactive oxygen species, we investigated the effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on kainate-induced in vivo oxidative damage in the rat hippocampus. A clinically relevant dose of nimesulide (6 mg/kg, i.p. ) was administered three times following kainate application (9 mg/kg, i.p.). After 24 h of kainate administration, the drastic decrease in hippocampal glutathione content and the significant increase in lipid peroxidation were attenuated in nimesulide-treated rats, suggesting that the induction of cyclooxygenase-2 is involved in kainate-mediated free radicals formation.


Assuntos
Inibidores de Ciclo-Oxigenase/farmacologia , Hipocampo/efeitos dos fármacos , Ácido Caínico/toxicidade , Estresse Oxidativo/efeitos dos fármacos , Sulfonamidas/farmacologia , Animais , Comportamento Animal/efeitos dos fármacos , Glutationa/efeitos dos fármacos , Glutationa/metabolismo , Hipocampo/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Ratos , Ratos Sprague-Dawley
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...